Surgery Partners, Inc. (NASDAQ: SGRY) is a Healthcare company (Medical - Care Facilities) with a market capitalization of $3.5B. The Maz Rating grades it against the other companies in its sector.
Surgery Partners, Inc.'s current Maz Rating and its five factor grades are for members: log in to see them.
At $26.85, Surgery Partners, Inc. trades at 1.0x sales and 2.1x book value, with an EV/EBITDA of 9.7. Over the last twelve months it generated about $3.4B of revenue and a net loss of $88M. It runs a gross margin of 21.1%, an operating margin of 11.3% and a net margin of -2.6%. It shows return on equity of -5.2%, return on invested capital of 4.5% and a free cash flow yield of 5.8%. On the balance sheet: a debt-to-equity ratio of 1.99 and a current ratio of 2.17. Over the past 52 weeks the share price ranged from $11.41 to $27.23, with a beta of 1.88.
Surgery Partners, Inc. does not currently pay a dividend.
23 Wall Street analyst ratings cover the stock: 11 Buy and 12 Hold, for a Hold consensus. This is the sell side's view, separate from the Maz Rating.
Figures are trailing twelve months unless stated. The Maz Rating and Maz Dividend Score rank a company against its own sector; they are not price targets or recommendations.